Wednesday, April 2, 2025
37.6 F
New York

Tag: regenerative medicine for diabetes

Breakthroughs in Type 2 Diabetes (NIDDM) Research: What Emerging Science Reveals About Insulin Resistance and Future Therapies

Type 2 diabetes, also known as non-insulin dependent diabetes mellitus (NIDDM), continues to pose an escalating global health burden. The rise in cases is closely tied to the surge in sedentary lifestyles, increasing obesity rates, and aging populations. According to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021, and type 2 diabetes accounted for more than 90% of those cases. This chronic condition not only affects glucose metabolism but is also intricately linked to cardiovascular disease, kidney failure, vision loss, and other serious complications. Despite decades of research, many questions remain about how to best manage, prevent, and potentially reverse type 2 diabetes.

Breakthroughs in Stem Cell Research: What the Latest Studies Reveal About Type 2 Diabetes and Emerging Success Rates of Therapy

Type 2 diabetes has long been recognized as one of the most pressing public health challenges of the 21st century. Characterized by insulin resistance and progressive beta-cell dysfunction, the condition affects over 400 million people globally, and the numbers continue to rise at an alarming pace. Despite advances in pharmacological treatments and lifestyle-based interventions, many patients struggle to achieve long-term glycemic control. Moreover, conventional therapies often address symptoms rather than the underlying pathology, prompting scientists to explore deeper, more transformative strategies. Among these, the potential of stem cell therapy has emerged as a particularly compelling frontier.